Amphotericin B
Application Notes
Amphotericin B is heptaene polyene antifungal originally discovered as a metabolite of Streptomyces nodosus in 1956. Amphotericin B acts by binding sterols in the cell membrane leading to the formation of transmembrane channels and subsequent ion leakage. Amphotericin B is poorly water soluble so has been developed for therapeutic use as a complex with desoxylate or in liposomes to improve bioavailability. Amphotericin B is widely used as a research reagent in diverse applications with over 15,000 literature citations.
References
- Amphotericins A and B, antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins. Vandeputte J. et al., Antibiot. Annu. 1955-1956. 1956, 587.
- Amphotericin B and its new derivatives – Mode of action. Baginski M. & Czub J. Current Drug Metabolism 2009, 10, 459.
- Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. Coukell A.J. & Brogden R.N. Drugs 1998, 55, 585.



